A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease

被引:15
|
作者
Dohnálek, J
Hasek, J
Dusková, J
Petroková, H
Hradilek, M
Soucek, M
Konvalinka, J
Brynda, J
Sedlácek, J
Fábry, M
机构
[1] Acad Sci Czech Republ, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610 6, Czech Republic
[3] Acad Sci Czech Republ, Inst Genet Mol, CR-16206 Prague 6, Czech Republic
关键词
D O I
10.1107/S0907444900018928
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Crystallization conditions for an HIV-1 protease-inhibitor complex were optimized to produce crystals suitable for X-ray diffraction experiments. The X-ray structure of the HIV-1 protease complex was solved and refined at 3.1 Angstrom resolution. In contrast to Saquinavir, the mimetic hydroxy group of the inhibitor Boc-Phe-Psi[(S)-CH(OH)CH2-NH]-Phe-Glu-Phe-NH2 is placed asymmetrically with respect to the non-crystallographic twofold axis of the protease dimer so that hydrogen bonds between the amino group of the inhibitor and the catalytic aspartates can be formed. The inhibitor binds in the centre of the active site by a compact network of hydrogen bonds to Gly27, Gly127, Asp25, Asp125 and via the buried water molecule W301 to Ile50 and Ile150.
引用
收藏
页码:472 / 476
页数:5
相关论文
共 50 条
  • [1] Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates.: A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor
    Dohnálek, J
    Hasek, J
    Dusková, J
    Petroková, H
    Hradilek, M
    Soucek, M
    Konvalinka, J
    Brynda, J
    Sedlácek, J
    Fábry, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (07) : 1432 - 1438
  • [2] LY316340 - A POTENT HIV-1 PROTEASE INHIBITOR CONTAINING A HIGH-AFFINITY OCTAHYDROTHIENOPYRIDINE HYDROXYETHYLAMINE ISOSTERE
    MUNROE, JE
    HORNBACK, WJ
    CAMPBELL, JB
    OUELLETTE, MA
    HATCH, SD
    MUESING, MA
    WISKERCHEN, MA
    BAXTER, AJ
    SU, K
    CAMPANALE, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (23) : 2885 - 2890
  • [3] Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor
    Backbro, K
    Lowgren, S
    Osterlund, K
    Atepo, J
    Unge, T
    Hulten, J
    Bonham, NM
    Schaal, W
    Karlen, A
    Hallberg, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 898 - 902
  • [4] The binding energy of HIV-1 protease inhibitor
    Ka, J
    Park, SH
    Kim, H
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 1996, 17 (01) : 19 - 24
  • [5] Binding free energy simulations of the HIV-1 protease and hydroxyethylene isostere inhibitors
    Won, Y
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2000, 21 (12): : 1207 - 1212
  • [6] Influence of inhibitor binding on HIV-1 protease dynamics
    Ringhofer, S
    Dutzler, R
    Kallen, J
    Andrew, P
    Visser, A
    Billich, A
    Scholz, D
    Gstach, H
    Steinhauser, O
    Schreiber, H
    Auer, M
    Kungl, A
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 65 : PA309 - PA309
  • [7] HIV-1 protease inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [8] Targeting structural flexibility in HIV-1 protease inhibitor binding
    Hornak, Victor
    Simmerling, Carlos
    DRUG DISCOVERY TODAY, 2007, 12 (3-4) : 132 - 138
  • [9] NOVEL BINDING MODE OF HIGHLY POTENT HIV-PROTEINASE INHIBITORS INCORPORATING THE (R)-HYDROXYETHYLAMINE ISOSTERE
    KROHN, A
    REDSHAW, S
    RITCHIE, JC
    GRAVES, BJ
    HATADA, MH
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) : 3340 - 3342
  • [10] MOLECULAR MECHANICS ANALYSIS OF INHIBITOR BINDING TO HIV-1 PROTEASE
    SANSOM, CE
    WU, J
    WEBER, IT
    PROTEIN ENGINEERING, 1992, 5 (07): : 659 - 667